首页 | 本学科首页   官方微博 | 高级检索  
检索        

耳聋左慈丸加味联合声治疗对肾精亏虚型耳鸣及抗氧化作用的观察
引用本文:王翔,谭业农,谢柳,吴小秦.耳聋左慈丸加味联合声治疗对肾精亏虚型耳鸣及抗氧化作用的观察[J].中国实验方剂学杂志,2018,24(23):189-193.
作者姓名:王翔  谭业农  谢柳  吴小秦
作者单位:海南省中医院
基金项目:海南省自然科学基金项目(20168310)
摘    要:目的:探讨耳聋左慈丸加味联合声治疗对肾精亏虚型耳鸣的临床疗效和对超氧化物歧化酶(SOD),丙二醛(MDA),谷胱甘肽过氧化物酶(GSH-Px),总抗氧化能力(T-AOC)指标的影响。方法:将79例患者随机按数字表法分为对照组39例和观察组40例。对照组采用声治疗,观察组在声治疗的基础上采用耳聋左慈丸加味内服。两组疗程均为连续治疗3个月。进行治疗前后耳鸣严重程度、耳鸣残疾评估量表(THI),用焦虑自评量表,睡眠自评量表(SRSS)和肾精亏虚证评分;检测治疗前后SOD,MDA,GSH-Px和T-AOC水平。结果:经秩和检验,观察组临床疗效优于对照组(Z=1.936,P0.05);观察组患者耳鸣残疾程度轻于对照组,差异有统计学意义(Z=1.848,P0.05);治疗后观察组患者耳鸣残疾程度轻于对照组,差异有统计学意义(Z=1.887,P0.05);治疗后观察组患者耳鸣严重程度,THI,SA,SRSS和肾精亏虚证评分均低于对照组(P0.01);治疗后观察组患者MDA水平低于对照组,SOD,GSH-Px和T-AOC水平均高于对照组(P0.01)。结论:在声治疗的基础上,耳聋左慈丸加味治疗肾精亏虚型耳鸣患者,可减轻耳鸣严重程度和耳鸣残疾程度,改善临床症状,并对焦虑和睡眠有明显的改善作用,还具有一定的抗氧自由基损伤作用,临床疗效优于单纯的声治疗。

关 键 词:耳鸣  肾精亏虚  耳聋左慈丸  声治疗  抗氧化作用
收稿时间:2018/6/27 0:00:00

Observation of Modified Erlong Zuoci Wan Combined with Acoustic Tinnitus with Deficiency of Kidney Essence and Antioxidation Effect
WANG Xiang,TAN Ye-nong,XIE Liu and WU Xiao-qin.Observation of Modified Erlong Zuoci Wan Combined with Acoustic Tinnitus with Deficiency of Kidney Essence and Antioxidation Effect[J].China Journal of Experimental Traditional Medical Formulae,2018,24(23):189-193.
Authors:WANG Xiang  TAN Ye-nong  XIE Liu and WU Xiao-qin
Institution:Hainan Provincial Hospital of Traditional Chinese Medicine, Haikou 570203, China,Hainan Provincial Hospital of Traditional Chinese Medicine, Haikou 570203, China,Hainan Provincial Hospital of Traditional Chinese Medicine, Haikou 570203, China and Hainan Provincial Hospital of Traditional Chinese Medicine, Haikou 570203, China
Abstract:Objective:To discuss the clinical efficacy of modified Erlong Zuoci Wan combined with acoustic therapy for tinnitus (deficiency of kidney essence), and investigate its effects on superoxide dismutase (SOD), malondialdehyde (MDA), glutathione peroxidase (GSH-Px) and total antioxidant capacity (T-AOC). Method:Seventy-nine patients were randomly divided into control group (39 cases) and observation group (40 cases) by random number table. Patients in control group got acoustic therapy. Based on the treatment in control group, patients in observation group additionally received modified Erlong Zuoci Wan. The treatment course was 3 months in both groups. Before and after treatment, scores of tinnitus severity, tinnitus handicap inventory (THI), self-rating anxiety scale (SAS), self-rating scale of sleep (SRSS) and deficiency of kidney essence were graded. Levels of SOD, MDA, GSH-Px and T-AOC were detected both before and after treatment. Result:In rank sum test, the clinical efficacy in observation group was superior to that in control group(Z=1.936,P<0.05). The degree of tinnitus disability in observation group was lighter than that in control group (P<0.05). Scores of tinnitus severity, THI, SAS, SRSS and deficiency of kidney essence symptoms in observation group were lower than those in control group (P<0.01). After treatment. Levels of MDA was lower and levels of SOD, GSH-Px and T-AOC were higher than those in control group (P<0.01). Conclusion:Based on acoustic therapy, modified Erlong Zuoci Wan can relieve tinnitus severity and the degree of tinnitus disability, ameliorate clinical symptoms, improve anxiety and sleeping, and it can also resist oxygen free radical damage, with better clinical efficacy than pure acoustic therapy.
Keywords:tinnitus  deficiency of kidney essence  Erlong Zuoci Wan  acoustic therapy  antioxidation effect
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号